Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Rescinnamine: Difference between pages

Content deleted Content added

VisualWikitext

@@ Line 1: / Line 1: @@
+{{short description|Chemical compound}}
-{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Rescinnamine|oldid=456667820}} 456667820] of page [[Rescinnamine]] with values updated to verified values.}}
 {{Drugbox
+| verifiedrevid = 464380960
-| Verifiedfields = changed
+| IUPAC_name = methyl (3β,16β,17α,18β,20α)-11,17-dimethoxy-18-<nowiki/>{[(2''E'')-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}yohimban-16-carboxylate
-| verifiedrevid = 408987920
-| IUPAC_name = methyl (3β,16β,17α,18β,20α)-11,17-dimethoxy-18-{[(2''E'')-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}yohimban-16-carboxylate
 | image = Rescinnamine.svg
+| image2 = [[File:Rescinnamine.png|frameless|rescinnamine 3D BS]]
+| width = 300
 <!--Clinical data-->
-| tradename =
+| tradename =  Moderil, Cinnasil, Anaprel
 | pregnancy_category =
 | legal_status = Rx-only
-| routes_of_administration = oral
+| routes_of_administration = [[Oral administration|By mouth]]
 <!--Pharmacokinetic data-->
 | bioavailability =
@@ Line 17: / Line 16: @@
 | metabolism =
 | elimination_half-life =
 <!--Identifiers-->
+| IUPHAR_ligand = 7098
-| CASNo_Ref = {{cascite|correct|CAS}}
 | CAS_number_Ref = {{cascite|correct|??}}
 | CAS_number = 24815-24-5
@@ Line 30: / Line 28: @@
 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
 | ChemSpiderID = 4444446
-| UNII_Ref = {{fdacite|changed|FDA}}
+| UNII_Ref = {{fdacite|correct|FDA}}
 | UNII = Q6W1F7DJ2D
 | KEGG_Ref = {{keggcite|correct|kegg}}
 | KEGG = D00198
-| ChEBI_Ref = {{ebicite|changed|EBI}}
+| ChEBI_Ref = {{ebicite|correct|EBI}}
 | ChEBI = 28572
 | ChEMBL_Ref = {{ebicite|correct|EBI}}
 | ChEMBL = 1668
 <!--Chemical data-->
 | C=35 | H=42 | N=2 | O=9
+| smiles = [H][C@]26C[C@@H](OC(=O)/C=C/c1cc(OC)c(OC)c(OC)c1)[C@H](OC)[C@@H](C(=O)OC)[C@@]2([H])C[C@]5([H])c4[nH]c3cc(OC)ccc3c4CCN5C6
-| molecular_weight = 634.716 g/mol
-| smiles = O=C(OC)[C@H]6[C@H]4C[C@@H]3c2nc1cc(OC)ccc1c2CCN3C[C@H]4C[C@@H](OC(=O)\C=C\c5cc(OC)c(OC)c(OC)c5)[C@@H]6OC
-| InChI = 1/C35H42N2O9/c1-40-21-8-9-22-23-11-12-37-18-20-15-29(46-30(38)10-7-19-13-27(41-2)33(43-4)28(14-19)42-3)34(44-5)31(35(39)45-6)24(20)17-26(37)32(23)36-25(22)16-21/h7-10,13-14,16,20,24,26,29,31,34,36H,11-12,15,17-18H2,1-6H3/b10-7+/t20-,24+,26-,29-,31+,34+/m1/s1
-| InChIKey = SZLZWPPUNLXJEA-QEGASFHIBN
 | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
 | StdInChI = 1S/C35H42N2O9/c1-40-21-8-9-22-23-11-12-37-18-20-15-29(46-30(38)10-7-19-13-27(41-2)33(43-4)28(14-19)42-3)34(44-5)31(35(39)45-6)24(20)17-26(37)32(23)36-25(22)16-21/h7-10,13-14,16,20,24,26,29,31,34,36H,11-12,15,17-18H2,1-6H3/b10-7+/t20-,24+,26-,29-,31+,34+/m1/s1
 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
 | StdInChIKey = SZLZWPPUNLXJEA-QEGASFHISA-N
-| synonyms = <small>methyl (1''R'',15''S'',17''R'',18''R'',19''S'',20''S'')-6,18-dimethoxy-17-{[(2''E'')-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.0<sup>2,10</sup>.0<sup>4,9</sup>.0<sup>15,20</sup>]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate</small>
+| synonyms = <small>methyl (1''R'',15''S'',17''R'',18''R'',19''S'',20''S'')-6,18-dimethoxy-17-<nowiki/>{[(2''E'')-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.0<sup>2,10</sup>.0<sup>4,9</sup>.0<sup>15,20</sup>]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate</small>
 }}
+'''Rescinnamine''', known by the brand names '''''Moderil''''', '''''Cinnasil''''', and '''''Anaprel''''', is an [[ACE inhibitor|angiotensin-converting enzyme inhibitor]] used as an [[antihypertensive]] [[medication|drug]].
+It is an indoloquinolizine [[alkaloid]] similar to [[reserpine]], obtained from ''[[Rauvolfia serpentina]]''<ref name="pmid13699407">{{cite journal |vauthors=FIFE R, MACLAURIN JC, WRIGHT JH |title=Rescinnamine in treatment of hypertension in hospital clinic and in general practice |journal=British Medical Journal |volume=2 |issue=5216 |pages=1848–50 |date=December 1960 |pmid=13699407 |pmc=2098607 |doi= 10.1136/bmj.2.5216.1848}}</ref> and other [[species]] of ''[[Rauvolfia]]''.<ref>{{cite journal |journal = Planta Med. |year = 1982 |volume = 44 |issue = 2 |pages = 91–3 |title = Alkaloids of Vinca major cv. Variegata. |vauthors = Balsevich J, Constabel F, Kurz WG |pmid = 17402086 |doi=10.1055/s-2007-971409}}</ref>
+== References ==
+{{reflist}}
+{{ACE inhibitors}}
+{{Angiotensin receptor modulators}}
+{{Tryptamines}}
+[[Category:Indoloquinolizines]]
+[[Category:Tryptamine alkaloids]]
+[[Category:Isoquinoline alkaloids]]
+[[Category:ACE inhibitors]]
+[[Category:Antihypertensive agents]]
+[[Category:Alkaloids found in Rauvolfia]]
+[[Category:Pyrogallol ethers]]
+[[Category:Cinnamate esters]]
+[[Category:Indole ethers at the benzene ring]]
+[[Category:Heterocyclic compounds with 5 rings]]
+[[Category:Methoxy compounds]]
+[[Category:Methyl esters]]
+{{Antihypertensive-stub}}